| 000 | 03283cam a2200661Ii 4500 | ||
|---|---|---|---|
| 001 | on1098179821 | ||
| 003 | OCoLC | ||
| 003 | UTCC | ||
| 005 | 20210825162443.0 | ||
| 006 | m d | ||
| 007 | cr |n||||||||| | ||
| 008 | 190423t20202020mou ob 000 0 eng d | ||
| 040 |
_aMMU _beng _erda _cMMU _dOCLCO _dCOU _dTMC _dCASUM _dOCLCO _dUAB _dOCLCO _dUIU _dN$T |
||
| 020 |
_a0323674879 _q(electronic book) |
||
| 020 |
_a9780323674874 _q(electronic bk.) |
||
| 020 |
_z9780323661386 _q(paperback) |
||
| 020 |
_z0323661386 _q(paperback) |
||
| 035 |
_a2243664 _b(N$T) |
||
| 035 | _a(OCoLC)1098179821 | ||
| 050 | 4 |
_aRM170 _b.G33 2020 |
|
| 060 | 4 |
_aWB 354 _bG136i 2020 |
|
| 082 | 0 | 4 | _a615.6 |
| 049 | _aMAIN | ||
| 100 | 1 |
_aGahart, Betty L., _eauthor. |
|
| 245 | 1 | 0 |
_aGahart's 2020 intravenous medications : _ba handbook for nurses and health professionals / _cBetty L. Gahart, Adrienne R. Nazareno, Meghan Q. Ortega. |
| 246 | 3 | 0 | _a2020 intravenous medications |
| 250 | _aThirty-sixth edition. | ||
| 264 | 1 |
_aSt. Louis, Mo. : _bElsevier, _c[2020] |
|
| 264 | 4 | _c©2020 | |
| 300 | _a1 online resource (xxii, 1409 pages) | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 500 | _aRevised edition of: Gahart's 2019 intravenous medications : a handbook for nurses and health professionals / Betty L. Gahart, Adrienne R. Nazareno, Meghan Q. Ortega. Thirty-fifth edition. [2019] | ||
| 504 | _aIncludes bibliographical references (page xxii). | ||
| 505 | 0 | _aGeneral dilution charts (inside front cover and facing page) -- How to use this book -- Preface -- Format and content of intravenous medications -- Key to abbreviations -- Important IV therapy facts -- Resources -- IV drugs [alphabetical drug monographs] -- Appendices. Recommendations for the safe use and handling of cytotoxic drugs -- FDA pregnancy categories -- U.S. Department of Health and Human Services, National Institutes of Health, and National Cancer Institute Common terminology criteria for adverse events -- Information for patients receiving immunosuppressive agents -- Recently approved drugs | |
| 588 | 0 | _aOnline resource; title from electronic title page (ClinicalKey, April 23, 2019). | |
| 590 | _aAdded to collection customer.56279.3 | ||
| 650 | 0 |
_aIntravenous therapy _vHandbooks, manuals, etc. |
|
| 650 | 0 |
_aNursing _vHandbooks, manuals, etc. |
|
| 650 | 7 |
_aIntravenous therapy. _2fast _0(OCoLC)fst00977816 |
|
| 650 | 7 |
_aNursing. _2fast _0(OCoLC)fst01041731 |
|
| 650 | 1 | 2 | _aInfusions, Intravenous. |
| 650 | 1 | 2 | _aInjections, Intravenous. |
| 655 | 4 | _aElectronic books. | |
| 655 | 2 | _aHandbook. | |
| 655 | 2 | _aNurses Instruction. | |
| 655 | 7 |
_aHandbooks and manuals. _2fast _0(OCoLC)fst01423877 |
|
| 655 | 7 |
_aHandbooks and manuals. _2lcgft |
|
| 700 | 1 |
_aNazareno, Adrienne R., _eauthor. |
|
| 700 | 1 |
_aOrtega, Meghan Q., _eauthor. |
|
| 776 | 0 | 8 |
_iPrint version: _aGahart, Betty L. _tGahart's 2020 intravenous medications. _dSt. Louis, Mo. : Elsevier, [2020] _z9780323661386 _w(OCoLC)1055686273 |
| 856 | 4 | 0 |
_3EBSCOhost _uhttp://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=2243664 |
| 850 | _aKCNL | ||
| 938 |
_aEBSCOhost _bEBSC _n2243664 |
||
| 994 |
_a92 _bN$T |
||
| 942 |
_2ddc _cEBK |
||
| 999 |
_c35006 _d35006 |
||